Vasomedical EECP Heart Failure PMA Study Redirected Toward CMS Coverage
This article was originally published in The Gray Sheet
Executive Summary
Vasomedical will use cost data from its prospective evaluation of EECP in congestive heart failure (PEECH) trial to support a national Medicare coverage request for counterpulsation therapy